Cardiovascular Systems () EV/EBITDA US GAAP (year values) |
||||||||
2020 | 2021 | 2022 | 2022 | LTM ? | ||||
EV/EBITDA | ? | -34.1 | -137.1 | -17.8 | -12.3 | -16.3 | ||
Changes by years, y/y, % | -98% | +303% | -100% | -31% |
Cardiovascular Systems. EV/EBITDA
Cardiovascular Systems. EV/EBITDA, changes, %
Cardiovascular Systems () EV/EBITDA US GAAP (quarter values) |
||||||||
2022Q4 | 2022Q4 | 2023Q1 | 2023Q1 | 2023Q2 | LTM ? | |||
EV/EBITDA | ? | -16.8 | -10.0 | -21.5 | -11.5 | -9.47 | -16.3 | |
Changes by years, y/y, % | -92% | -95% | +1% | -46% | ||||
Changes by quarters, q/q, % | -24% | -40% | +114% | -46% | -18% |